[1] 中华医学会肝病学分会、中华医学会感染病学分会. 慢性乙型肝炎防治指南(2010年版)[J].中华肝脏病杂志, 2011, 19(1): 13-24.
[2] Palumbo E, Scotto G, Cibelli DC, et al. Immigration and hepatitis B virus: epidemiological, clinical and therapeutic aspects[J]. East Mediterr Health J, 2008, 14(4):784-790.
[3] Yin J, Zhang H, He Y, et al. Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in mainland China: a community-based study[J]. Cancer Epidemiol Biomarkers Prev, 2010, 19(3):777-786.
[4] 荣海燕,张 琼,张朝霞.新疆地区乙型肝炎患者HBV基因型与耐药突变的相关性研究[J].中华检验医学杂志, 2012, 35(12):1209-1211.
[5] Rebecca TH. Diagnostic and clinical relevance of HBV mutations[J]. Labmedicine, 2011, 42:488-496.
[6] Fung J, Lai CL, Seto WK, et al. Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B[J]. J Antimicrob Chemother, 2011, 66(12):2715-2725.
[7] Lin CL, Chien RN, Hu CC, et al. Identification of hepatitis B virus rtS117F substitution as a compensatory mutation for rtM204I during lamivudine therapy[J]. J Antimicrob Chemother, 2012, 67(1):39-48.
[8] 李晓斐,王丽娜. 乙型肝炎病毒YMDD变异与基因分型及临床关系的研究[J]. 检验医学,2011,26(7):479-481.
[9] Qin Y, Tang X, Garcia T, et al. Hepatitis B virus genotype C isolates with wild-type core promoter sequence replicate less efficiently than genotype B isolates but possess higher virion secretion capacity[J]. J Virol, 2011, 85 (19):10167-10177. |